SPRAGUE JOHN M (Chief Financial Officer) exercised options at T2 BIOSYSTEMS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/28/2022ACC: 0000899243-22-008056
Officer· Chief Financial Officer
Since Jul 2018
-55.01K
Net shares
Net seller
$24.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
145.72K acquired · 200.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+145.72K
Price / share
—
Trade value
—
% of position
320.4%
2/24/2022
45.48K→191.20K
Common Stock
Direct
Shares
−55.01K
Price / share
$0.45
Trade value
$24.69K
% of position
28.8%
2/24/2022
191.20K→136.20K
Total
Net shares
+90.71K
Net value
-$24.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2022 | M · Option Exercise | +145.72K | — | — | 320.4% | 45.48K | 191.20K |
| Common Stock Direct | 2/24/2022 | F · Tax Withholding | −55.01K | $0.45 | $24.69K | 28.8% | 191.20K | 136.20K |
| Total | +90.71K | -$24.69K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
145.72K shares
Shares
−145.72K
Strike price
Held after
291.44K
Exercisable
—
2/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock145.72K shares | 2/24/2022 | M · Option Exercise | −145.72K | — | 291.44K |